July 2018
Volume 59, Issue 9
Open Access
ARVO Annual Meeting Abstract  |   July 2018
Prevalence of Ocular Findings in Patients with Central Nervous System Tumor in a Tertiary Hospital
Author Affiliations & Notes
  • Sabrina Jisun Myung Cho
    Ophthalmology and Visual Sciences, Federal University of Sao Paulo, Sao Paulo, SP, Brazil
  • Carolina Pelegrini Gracitelli
    Ophthalmology and Visual Sciences, Federal University of Sao Paulo, Sao Paulo, SP, Brazil
  • Danilo A. Paulo
    Ophthalmology and Visual Sciences, Federal University of Sao Paulo, Sao Paulo, SP, Brazil
  • Luciana da Cruz Noia
    Ophthalmology and Visual Sciences, Federal University of Sao Paulo, Sao Paulo, SP, Brazil
  • Footnotes
    Commercial Relationships   Sabrina Cho, None; Carolina Gracitelli, None; Danilo Paulo, None; Luciana Noia, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science July 2018, Vol.59, 5607. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      Sabrina Jisun Myung Cho, Carolina Pelegrini Gracitelli, Danilo A. Paulo, Luciana da Cruz Noia; Prevalence of Ocular Findings in Patients with Central Nervous System Tumor in a Tertiary Hospital. Invest. Ophthalmol. Vis. Sci. 2018;59(9):5607.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Purpose : The main cause of mortality from neoplasm in children is the central nervous system (CNS) tumor, for this reason, there is an increasing effort to provide data to earlier detection and treatment of this disease. The purpose of this study was to describe the prevalence of ocular findings in children with CNS tumors that were followed up in a Center of Pediatric Oncology in São Paulo, Brazil.

Methods : An observational study was carried out. Information of demographic and ocular data were collected between Sep 2016 and Sep 2017 from the hospital medical records from pediatric patients aged from 0 to 19 years, with CNS tumor that were being followed up in a tertiary hospital, and were systematically referred to the Neurophthalmology outpatient clinic for evaluation, despite presence of visual symptoms or findings.

Results : A total of 230 eyes of 115 patients were included. The mean age of all participants was 10.08±4.85 years (range 1-19 years). 51.9% of all participants were male. Out of the 104 patients that reported visual acuity (VA), 51 (49%) had reduced VA. The mean best-corrected visual acuity (BCVA) was 0.28±0.38 logMAR (range 0-1 logMAR). 33.2% of all participants presented alteration of extrinsic ocular motility (EOM). No participant had exophthalmia and only 8 (8.5%) had papillary edema. 21 patients (21%) had optic atrophy and 3 (2.9%) of them did not present any CNS tumor. Based on the diagnosis, most of them were gliomas (55.6%), followed by craniopharyngiomas (15.1%), germ cell tumors (11.3%), and both ganglioglioma (1.9%) and leukemia (1.9%). Mean age in patients with glioma was 9.4±4.68 years (range 1-18 years), with no sex preference and mean BCVA of 0.27 ± 0.34 LogMAR. 18.6% had neurofibromatosis and optic nerve glioma. Mean age in patients with craniopharyngioma was 12.62±4.16 years (range 7-19 years), 62.5% were male, and the mean BCVA was of 0.35±0.42 LogMAR. In patients with germ cell tumor, the mean age was 11.75±3.93 years (range 2-19 years), 58.3% were male and the mean BCVA was of 0.25±0.44 LogMAR.

Conclusions : The most prevalent diagnosis were glioma and craniopharyngioma. Patients with craniopharyngioma were older, with male preference and worse VA than those with glioma or germ cell tumor. Almost one fifth of the patients with glioma had neurofibromatosis. We reinforce the importance a complete ocular exam in children with CNS tumor suspicion even without any symptoms.

This is an abstract that was submitted for the 2018 ARVO Annual Meeting, held in Honolulu, Hawaii, April 29 - May 3, 2018.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×